KPMA exerting to extend tax privilege due for drug R&D.

The Korea Pharmaceutical Manufacturers Association (KPMA) is working hard to extend the due period of tax exemption for the drug R&D expenditures, which will expire at the end of this year according to a special tax provision.

Vice chairman Moon Gyeong-tae of KPMA met with an aide to Rep. Chang Ki-tae of National Assembly Health and Welfare Committee, asking for the extension of the tax exem...